Spectranetics acquires Covidien's Stellarex DCB for $30mm
Spectranetics Corp. (medical devices for use in minimally invasive cardiovascular procedures) paid $30mm to buy Covidien PLC’s Stellarex drug-coated balloon (DCB) platform.
- Medical Devices
- Drug Delivery
Surgical Equipment & Devices
- Minimally or Less Invasive
- Surgical Equipment & Devices
- Marketing (Licensing)
- Product Purchase
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.